144 related articles for article (PubMed ID: 24357175)
21. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
[TBL] [Abstract][Full Text] [Related]
23. Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.
Braun B; Khil L; Tio J; Krause-Bergmann B; Fuhs A; Heidinger O; Hense HW
Dtsch Arztebl Int; 2018 Aug; 115(31-32):520-527. PubMed ID: 30149831
[TBL] [Abstract][Full Text] [Related]
24. A new concept to ensure data privacy and data security in cancer registries.
Michaelis J; Miller M; Pommerening K; Schmidtmann I
Medinfo; 1995; 8 Pt 1():661-5. PubMed ID: 8591293
[TBL] [Abstract][Full Text] [Related]
25. Episode sensitivity in association with process indicators in the Finnish breast cancer screening program.
Sarkeala T; Hakama M; Saarenmaa I; Hakulinen T; Forsman H; Anttila A
Int J Cancer; 2006 Jan; 118(1):174-9. PubMed ID: 16003756
[TBL] [Abstract][Full Text] [Related]
26. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
27. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
28. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
[TBL] [Abstract][Full Text] [Related]
29. [Results of the Czech National Breast Cancer screening programme].
Skovajsová M; Májek O; Daneš J; Bartoňková H; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():69-78. PubMed ID: 25494891
[TBL] [Abstract][Full Text] [Related]
30. Radiologist interpretive volume and breast cancer screening accuracy in a Canadian organized screening program.
Théberge I; Chang SL; Vandal N; Daigle JM; Guertin MH; Pelletier E; Brisson J
J Natl Cancer Inst; 2014 Mar; 106(3):djt461. PubMed ID: 24598715
[TBL] [Abstract][Full Text] [Related]
31. Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study.
Khil L; Heidrich J; Wellmann I; Kääb-Sanyal V; Weigel S; Heindel W; Hense HW; Heidinger O
BMC Cancer; 2020 Mar; 20(1):174. PubMed ID: 32131766
[TBL] [Abstract][Full Text] [Related]
32. Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from the German mammography screening programme.
Buschmann L; Wellmann I; Bonberg N; Wellmann J; Hense HW; Karch A; Minnerup H
BMC Med; 2024 Jan; 22(1):43. PubMed ID: 38287392
[TBL] [Abstract][Full Text] [Related]
33. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
34. Missed and true interval and screen-detected breast cancers in a population based screening program.
Hoff SR; Samset JH; Abrahamsen AL; Vigeland E; Klepp O; Hofvind S
Acad Radiol; 2011 Apr; 18(4):454-60. PubMed ID: 21216632
[TBL] [Abstract][Full Text] [Related]
35. Pan-Canadian study of mammography screening and mortality from breast cancer.
Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
[TBL] [Abstract][Full Text] [Related]
36. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
37. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
Foca F; Mancini S; Bucchi L; Puliti D; Zappa M; Naldoni C; Falcini F; Gambino ML; Piffer S; Sanoja Gonzalez ME; Stracci F; Zorzi M; Paci E;
Cancer; 2013 Jun; 119(11):2022-8. PubMed ID: 23504860
[TBL] [Abstract][Full Text] [Related]
38. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
39. A review of interval breast cancers diagnosed among participants of the Nova Scotia Breast Screening Program.
Payne JI; Caines JS; Gallant J; Foley TJ
Radiology; 2013 Jan; 266(1):96-103. PubMed ID: 23169791
[TBL] [Abstract][Full Text] [Related]
40. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
